Coloplast agrees to acquire Kerecis for up to $1.3B

Coloplast signed an agreement to acquire Kerecis, a biologics wound care company, for up to USD 1.3 billion, with an upfront cash payment of USD 1.2 billion. Kerecis is based in Ísafjörður, Iceland, and uses fish skin technology for wound healing.

“We're excited to join the Coloplast family and have their support in becoming the world leader in tissue regeneration.”kerecis.com

• 1 source
• kerecis.comColoplast announces agreement to acquire Kerecis and raises long-term growth expectations - KerecisJul 7, 2023

Summarized from public sources; check the original articles before acting on it.